ERIN MCDONOUGH-MAYO: Open Payments
NPI 1861860942 · SEWICKLEY, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,763 in 92 payments from 24 companies in 2025. Trend: 2023 $1,367 · 2024 $1,726 · 2025 $1,763
Food & beverage: $1,763
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 15 | $272 |
| Lilly USA, LLC | 13 | $268 |
| Ascendis Pharma Endocrinology Inc | 9 | $168 |
| Amphastar Pharmaceuticals, Inc. | 6 | $116 |
| Tandem Diabetes Care, Inc. | 7 | $112 |
| Bayer Healthcare Pharmaceuticals Inc. | 6 | $100 |
| Amgen Inc. | 5 | $99 |
| Xeris Pharmaceuticals, Inc. | 4 | $81 |
| Dexcom, Inc. | 3 | $69 |
| Madrigal Pharmaceuticals | 3 | $64 |
Products named: MOUNJARO, Yorvipath, Wegovy, t:slim X2 Insulin Pump with Control-IQ, Kerendia, JARDIANCE, Rybelsus, Dexcom G6 Transmitter.
Industry payments across PA — which companies pay providers there.
